Drugs / LAS41004 IMP5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02111499 | Mar → May 2014 | psoriasis | Almirall, S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAS41004 IMP5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02111499 ↗ |
| Route | Topical | “once daily, topical” NCT02111499 ↗ |